Ownership and insider activity for Aditxt, Inc. (ADTX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions.
Price
| Price | $0.01 |
| Market Cap | $5M |
| Exchange | OTC |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-23 | Takeover Time 2026 LLC | S-Sale | 3,420,439 | $68K |
| 2026-06-18 | HRT FINANCIAL LP | P-Purchase | 7,340,178 | $95K |
| 2026-06-22 | HRT FINANCIAL LP | S-Sale | 5,120,480 | $92K |
| 2026-06-18 | HRT FINANCIAL LP | |||
| 2026-06-22 | Tai Wey Ann | |||
| 2026-06-16 | Tai Wey Ann | |||
| 2026-06-12 | Takeover Time 2026 LLC | |||
| 2026-06-16 | HRT FINANCIAL LP | S-Sale | 3,132,480 | $41K |
| 2026-06-17 | DRW Securities, LLC | S-Sale | 126,772 | $1K |
| 2026-06-15 | HRT FINANCIAL LP | P-Purchase | 2,114,344 | $30K |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25000 | $115709 | $4090 | $10.5M | $7.9M | $2.8M | $97102 | $833031 | $3.2M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $832.2M | 0 |
| Receivables | 0 | 0 | 0 | 0 | $589844 | $527961 | $5.9M | $1.2M | 0 |
| Inventory | 0 | 0 | 0 | 0 | $494697 | $950093 | $745502 | $11245 | $5774 |
| Total Current Assets | $25000 | $115709 | $4090 | $11.0M | $9.4M | $4.7M | $6.9M | $2.0M | $3.8M |
| Property, Plant & Equipment | 0 | 0 | 0 | $1.7M | $6.4M | $5.5M | $4.1M | $2.8M | $2.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | $321000 | $214000 | $107000 | $9444 | $6111 | $2778 |
| Total Assets | $25000 | $115709 | $123532 | $13.1M | $16.7M | $10.7M | $44.6M | $32.1M | $16.5M |
| Accounts Payable | $8566 | $1.1M | $1.8M | $241613 | $1.6M | $2.0M | $8.6M | $10.2M | $7.3M |
| Short-term Debt | 0 | $163602 | $165600 | $587588 | $700433 | $409983 | $16.2M | $5.8M | $1.9M |
| Total Current Liabilities | $59900 | $1.7M | $3.0M | $1.2M | $3.6M | $3.6M | $25.9M | $23.4M | $12.2M |
| Long-term Debt | 0 | 0 | 0 | 0 | $110041 | 0 | 0 | 0 | 0 |
| Total Liabilities | $84900 | $1.7M | $3.0M | $2.1M | $6.5M | $5.5M | $28.5M | $23.9M | $12.6M |
| Retained Earnings | -$212986 | -$5.9M | -$11.7M | -$20.9M | -$67.4M | -$95.0M | -$127.7M | -$168.1M | -$209.8M |
| Total Equity | -$59900 | -$1.5M | -$2.9M | $11.0M | $10.2M | $5.2M | $16.1M | $8.9M | $5.6M |
| Total Debt | 0 | $163602 | $165600 | $1.8M | $4.7M | $3.4M | $18.2M | $6.9M | $3.0M |
| Net Debt | -$25000 | $47893 | $161510 | -$8.7M | -$3.2M | $613219 | $18.1M | -$826.1M | -$192071 |
| Working Capital | -$34900 | -$1.5M | -$3.0M | $9.8M | $5.8M | $1.1M | -$19.0M | -$21.4M | -$8.4M |
Financial Health
| Debt / Equity | -0.13 |
| Current Ratio | 0.06 |
Profitability
| Return on Equity | 926.02% |
| Return on Invested Capital | -406.31% |
| Return on Assets | -373.57% |
| Gross Margin | 19.89% |
| Operating Margin | -127821.37% |
| Net Margin | -362385.72% |
Related companies: AIMD · ANL · APLM · ATHA · BLRX · CTXR · GOVX
Explore sector: Healthcare · Biotechnology
More sections of ADTX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks